Program
nintedanib
Also written as “Nintedanib”, “BIBF 1120” and “Nintedanib (BIBF1120)”.
Its studies are mostly in Idiopathic Pulmonary Fibrosis · Carcinoma, Non-Small-Cell Lung · Pulmonary Fibrosis · Lung Diseases, Interstitial · Neoplasms, led by 3 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Boehringer Ingelheim | 620 open or running | phase 4since Oct 16, 2015 | Aug 9, 2007 | none ahead |
| Mannkind | 10 open or running | phase 1since Jan 7, 2026 | Jan 7, 2026 | none ahead |
| PureTech | 10 open or running | phase 1since Nov 20, 2024 | Nov 20, 2024 | none ahead |
Also a collaborator on its studies: novotech-australia-pty-limited and parexel.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 46 studies since Aug 5, 2008.
- Apr 22, 2016Phase 1 study in Carcinoma, Non-Small-Cell LungBoehringer Ingelheim · NCT02751385 · 2 enrolled · Germany
- May 20, 2016Phase 2 study in Colorectal NeoplasmsBoehringer Ingelheim · NCT02780700 · 1 enrolled · United States
- May 27, 2016Phase 4 study in Idiopathic Pulmonary FibrosisBoehringer Ingelheim · NCT02788474 · 347 enrolled · United States, Australia, Belgium and more
- Dec 19, 2016Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT02999178 · 663 enrolled · United States, Argentina, Belgium and more
- Oct 13, 2017Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT03313180 · 444 enrolled · United States, Argentina, Australia and more
- Sep 17, 2018Phase 1 study in Scleroderma, SystemicBoehringer Ingelheim · NCT03675581 · 17 enrolled · Belgium, France, Germany and more
- Jan 28, 2019Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT03820726 · 435 enrolled · United States, Argentina, Belgium and more
- Sep 16, 2019Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT04093024 · 39 enrolled · United States, Argentina, Australia and more
- Jun 23, 2021Phase 1 study in HealthyBoehringer Ingelheim · NCT04938453 · 20 enrolled · Germany
- Sep 30, 2021Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT05065190 · 81 enrolled · China
- Mar 10, 2022Phase 3 study in Lung Diseases, InterstitialBoehringer Ingelheim · NCT05285982 · 54 enrolled · United States, Argentina, Belgium and more
- Oct 2, 2023Phase 1 study in HealthyBoehringer Ingelheim · NCT06070610 · 14 enrolled · Germany
- Nov 20, 2024PureTech's first study: phase 1 study in Pulmonary FibrosisNew to PureTechPureTech · NCT06717100 · 24 enrolled · Australia
- Jan 7, 2026Mannkind's first study: phase 1 study in Idiopathic Pulmonary FibrosisNew to MannkindMannkind · NCT07344558 · 27 enrolled · United States
TargetBeta
“Platelet-derived growth factor receptor inhibitor; Vascular endothelial growth factor receptor inhibitor; Fibroblast growth factor receptor inhibitor”ChEMBL 37, by rule
Studies
The newest 60 of 64 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07344558Idiopathic Pulmonary Fibrosis · United States | 1 | Completed | Mannkind | Jun 17, 2026 | 27 |
| NCT06717100Pulmonary Fibrosis · Australia | 1 | Completed | PureTech | Feb 17, 2025 | 24 |
| NCT06070610Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Dec 14, 2023 | 14 |
| NCT05285982Lung Diseases, Interstitial · United States, Argentina, Belgium and more | 3 | Completed | Boehringer Ingelheim | Aug 13, 2025 | 54 |
| NCT05065190Lung Diseases, Interstitial · China | 3 | Completed | Boehringer Ingelheim | Apr 30, 2024 | 81 |
| NCT04938453Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Aug 30, 2021 | 20 |
| NCT04093024Lung Diseases, Interstitial · United States, Argentina, Australia and more | 3 | Completed | Boehringer Ingelheim | May 24, 2022 | 39 |
| NCT03820726Lung Diseases, Interstitial · United States, Argentina, Belgium and more | 3 | Completed | Boehringer Ingelheim | Aug 30, 2022 | 435 |
| NCT03675581Scleroderma, Systemic · Belgium, France, Germany and more | 1 | Completed | Boehringer Ingelheim | Oct 9, 2019 | 17 |
| NCT03313180Lung Diseases, Interstitial · United States, Argentina, Australia and more | 3 | Completed | Boehringer Ingelheim | Jan 25, 2023 | 444 |
| NCT02999178Lung Diseases, Interstitial · United States, Argentina, Belgium and more | 3 | Completed | Boehringer Ingelheim | Apr 23, 2019 | 663 |
| NCT02788474Idiopathic Pulmonary Fibrosis · United States, Australia, Belgium and more | 4 | Completed | Boehringer Ingelheim | Aug 4, 2017 | 347 |
| NCT02780700Colorectal Neoplasms · United States | 2 | Terminated | Boehringer Ingelheim | Sep 9, 2016 | 1 |
| NCT02751385Carcinoma, Non-Small-Cell Lung · Germany | 1 | Terminated | Boehringer Ingelheim | Nov 28, 2017 | 2 |
| NCT02668393Carcinoma, Non-Small-Cell Lung · France, Germany | 1 | Completed | Boehringer Ingelheim | Nov 27, 2019 | 14 |
| NCT02667704Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Mar 2016 | 13 |
| NCT02606877Idiopathic Pulmonary Fibrosis · United Kingdom | 4 | Completed | Boehringer Ingelheim | Mar 22, 2017 | 37 |
| NCT02579603Idiopathic Pulmonary Fibrosis · United States, Canada, France and more | 4 | Completed | Boehringer Ingelheim | Jan 3, 2017 | 105 |
| NCT02597933Scleroderma, Systemic · United States, Argentina, Australia and more | 3 | Completed | Boehringer Ingelheim | Oct 31, 2018 | 580 |
| NCT02572752Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Nov 2015 | 70 |
| NCT02300298Carcinoma, Non-Small-Cell Lung · Japan | 1 | Completed | Boehringer Ingelheim | Jan 15, 2016 | 10 |
| NCT02231164Carcinoma, Non-Small-Cell Lung · United States, Georgia, Thailand | 3 | Terminated | Boehringer Ingelheim | Dec 24, 2015 | 12 |
| NCT02191865Hepatic Insufficiency · Germany | 1 | Completed | Boehringer Ingelheim | Dec 2014 | 33 |
| NCT02182258Healthy | 1 | Completed | Boehringer Ingelheim | Aug 2009 | 30 |
| NCT02182245Genital Neoplasms, Female | 1 | Completed | Boehringer Ingelheim | Jan 1, 2007 | 22 |
| NCT02182219Prostatic Neoplasms | 1 | Completed | Boehringer Ingelheim | Apr 1, 2007 | 21 |
| NCT02182206Neoplasms | 1 | Completed | Boehringer Ingelheim | Jun 2005 | 50 |
| NCT02182193Healthy | 1 | Completed | Boehringer Ingelheim | Nov 2006 | 54 |
| NCT02182154Healthy | 1 | Completed | Boehringer Ingelheim | Nov 2005 | 8 |
| NCT02182141Multiple Myeloma | 1 | Completed | Boehringer Ingelheim | Mar 2005 | 17 |
| NCT02182128Neoplasms | 1 | Completed | Boehringer Ingelheim | Jun 2009 | 24 |
| NCT02182102Carcinoma, Non-Small-Cell Lung | 1 | Completed | Boehringer Ingelheim | May 2010 | 26 |
| NCT02182076Healthy | 1 | Completed | Boehringer Ingelheim | Nov 2005 | 15 |
| NCT02182063Prostatic Neoplasms | 2 | Completed | Boehringer Ingelheim | Jan 2007 | 81 |
| NCT02182050Carcinoma, Non-Small-Cell Lung | 2 | Completed | Boehringer Ingelheim | Jan 2007 | 73 |
| NCT02149108Colorectal Neoplasms · United States, Argentina, Australia and more | 3 | Completed | Boehringer Ingelheim | May 13, 2016 | 768 |
| NCT01979952Idiopathic Pulmonary Fibrosis · United States, Canada, Turkey | 3 | Completed | Boehringer Ingelheim | Oct 27, 2016 | 113 |
| NCT01951846Malignant Solid Tumour · Germany | 1 | Completed | Boehringer Ingelheim | Nov 2004 | 61 |
| NCT01907100Mesothelioma · United States, Argentina, Australia and more | 3 | Terminated | Boehringer Ingelheim | Mar 16, 2018 | 545 |
| NCT01770392Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Mar 2013 | 26 |
| NCT01679613Healthy · Germany | 1 | Completed | Boehringer Ingelheim | Nov 2012 | 34 |
| NCT01619085Idiopathic Pulmonary Fibrosis · United States, Australia, Belgium and more | 3 | Completed | Boehringer Ingelheim | Jul 5, 2017 | 752 |
| NCT01594125Carcinoma, Hepatocellular · Japan | 1 | Completed | Boehringer Ingelheim | Nov 2014 | 30 |
| NCT01417156Pulmonary Fibrosis · Japan | 2 | Completed | Boehringer Ingelheim | Oct 2015 | 20 |
| NCT01346540Carcinoma, Non-Small-Cell Lung · Italy, Netherlands, Spain and more | 1 | Completed | Boehringer Ingelheim | Apr 25, 2013 | 16 |
| NCT01335477Pulmonary Fibrosis · United States, Canada, Chile and more | 3 | Completed | Boehringer Ingelheim | Oct 2013 | 551 |
| NCT01335464Pulmonary Fibrosis · United States, Australia, Belgium and more | 3 | Completed | Boehringer Ingelheim | Oct 2013 | 515 |
| NCT01170065Pulmonary Fibrosis · Argentina, Australia, Belgium and more | 2 | Completed | Boehringer Ingelheim | Sep 26, 2016 | 198 |
| NCT01136174Idiopathic Pulmonary Fibrosis · Japan | 2 | Completed | Boehringer Ingelheim | Mar 2011 | 50 |
| NCT01022853Neoplasms · Italy | 1 | Completed | Boehringer Ingelheim | Feb 2013 | 30 |
| NCT01024920Carcinoma, Renal Cell · Hungary, Poland, Romania and more | 2 | Completed | Boehringer Ingelheim | Nov 8, 2011 | 99 |
| NCT01015118Ovarian Neoplasms · United States, Australia, Austria and more | 3 | Completed | Boehringer Ingelheim | Apr 1, 2013 | 1,366 |
| NCT00998296Neoplasms · France | 1 | Completed | Boehringer Ingelheim | Dec 2012 | 70 |
| NCT01004003Carcinoma, Hepatocellular · Austria, France, Germany and more | 2 | Completed | Boehringer Ingelheim | Jul 14, 2014 | 125 |
| NCT00987935Carcinoma, Hepatocellular · Korea, Republic of, Taiwan | 2 | Completed | Boehringer Ingelheim | Jul 2014 | 134 |
| NCT00979576Carcinoma, Non-Small-Cell Lung · Japan | 1 | Terminated | Boehringer Ingelheim | Feb 16, 2015 | 19 |
| NCT00806819Carcinoma, Non-Small-Cell Lung · United States, Argentina, Australia and more | 3 | Completed | Boehringer Ingelheim | Jun 2011 | 718 |
| NCT00805194Carcinoma, Non-Small-Cell Lung · Austria, Belarus, Belgium and more | 3 | Completed | Boehringer Ingelheim | Nov 2, 2010 | 1,314 |
| NCT00801294Colorectal Neoplasms · France | 2 | Completed | Boehringer Ingelheim | Nov 1, 2007 | 46 |
| NCT00730821Neoplasms · United States | 1 | Completed | Boehringer Ingelheim | Aug 2009 | 28 |
How it is read
Names in the registry
- “Nintedanib”, 43 entries
- “BIBF 1120”, 26 entries
- “nintedanib”, 4 entries
- “Nintedanib (BIBF1120)”, 2 entries
- “Nintedanib high dose”, 2 entries
Codes read as this program: MNKD201.
Conditions, from the studies’ own filings
- Idiopathic Pulmonary Fibrosis, 13 studies
- Carcinoma, Non-Small-Cell Lung, 10 studies
- Pulmonary Fibrosis, 6 studies
- Lung Diseases, Interstitial, 6 studies
- Neoplasms, 6 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.